Upcoming SF event: Engaging and Working With Opinion Leaders to Support Commercial Success

On October 2, join the HBA San Francisco chapter explore current practice across diagnostics, device and pharma industries in engaging key opinion leaders (KOLs) in the development and delivery of disease education, as well as evidence of clinical utility and cost effectiveness. Case studies will demonstrate how to work with KOLs to educate the community, support prescriber adoption of new products, and satisfy payors in US and global markets. Click here to register for this dynamic discussion sponsored and hosted by Genomic Health.

News Categories: